https://www.selleckchem.com/pr....oducts/gsk-2837808A.
sistance to CRT through downstream IL-4 signaling affecting the progress of cell proliferation and apoptosis. The high expression of VSTM2L induced resistance to CRT, and adverse survival outcomes served as a prognostic factor in patients with rectal cancer receiving pCRT, suggesting that VSTM2L high expression may be a potential resistant predictable biomarker for LARC patients receiving pCRT. The high expression of VSTM2L induced resistance to CRT, and adverse survival outcomes served as a prognostic factor in patients with recta